Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
BLOG
EVENT CALENDAR
COLUMNS
WHITE PAPERS
THE MAGAZINE
  Pharmaceutical Technology Europe E-Alert
 
24 June 2011

IN THIS ISSUE
• Social media guidance
• FDA tackles imports
• Novartis in Russia
• Print ads unclear
 
ABPI releases social media guidance
The Association of the British Pharmaceutical Industry (ABPI) has published a guidance that suggests best practices for managing adverse events from the internet and social media. More...
 
FDA tackles imports and the supply chain
The FDA has released a new strategy aimed at meeting the challenges posed by rapidly rising imports, which have quadrupled since 2000, of FDA-regulated products and the growing complexity of the pharmaceutical supply chain. More...
 
Novartis invests in Russia
Novartis has commenced construction of a new manufacturing plant in Russia that represents the company’s most significant investment in that country to date. The facility will produce innovative and generic products and will create 350 jobs in Saint Petersburg. More...
 
Study finds traditional print drug ads unclear
The traditional method of conveying information in the brief summary of a printed prescription-drug advertisement is neither the most comprehensible nor the most preferred by consumers, according to an FDA study published online this week in Medical Decision Making. More...
 
J&J issues voluntary recall of Risperdal
Ortho-McNeil-Janssen, a subsidiary of Johnson & Johnson, has initiated a voluntary recall of its antipsychotic medication Risperdal because of an unusual odour. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
To Russia, with pharma
Is Biotech following in Big Pharm's footsteps
Cordis to axe up to 1000 jobs
More blog posts

Latest articles
The EMA and EU expansion
Annex 11: progress in EU computer systems guidelines
The single-use technology world tour
More articles

Upcoming events
Social Media in the Pharmaceutical Industry (6–7 July | UK)
Biostatistics for Non-Statisticians (11–13 July | Switzerland)
CPhI Japan (13–15 July | Japan)
More events

Product/Service Profiles
Oxoid

Genetic Identification and Characterization in less than 8 Hours
The DuPont Qualicon RiboPrinter® microbial characterization system provides the speed, accuracy and resolution needed to identify bacteria and compare them at the strain level characterization, all in less than 8 hours. This automated system is available in Europe, Canada and Australia alongside Oxoid products. Read more
 
Shimadzu

Leading lights in TOC
Shimadzu’s new TOC-L Series combines the proven combustion catalytic oxidation at 680°C and NDIR detection method with user friendly design. Read more

Event profile

placeholder

 

 


Pharma Outsourcing & Procurement Summit 2011
26-27 September 2011
Berlin, Germany

Delivering COG reduction and efficiency gains through external manufacturing and procurement strategies Pharmaceutical Technology Europe subscribers get 20% off. Read more
 


Survey
Should the regulation of atypical actives (i.e., the use of an excipient as an active ingredient in a drug) be changed?
■ Atypical actives should continue to be reviewed and regulated as excipients 9%
 
■ Atypical actives should be reviewed and regulated in the same way as regular active ingredients 33%
     
■ Review and regulation of atypical actives should be determined on a case-by-case basis 58%

This week we would like to know...

Do you believe that a single corporate strategy is sufficient for the fragmented nature of the emerging markets?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.